Skip to content

← All stories

Markets

UBS reiterates Buy on Summit Therapeutics stock, $33 target

1 source ·1 article ·52m ago

Covered by 1 outlet

All coverage · 1 article

Investing.com News ·52m ago

UBS reiterates Buy on Summit Therapeutics stock, $33 target